Physician
Integrated Regional Laboratories Pathology Services, LLC
Integrated Regional Laboratories Pathology Services, LLC was paid $564K by Medicaid between Dec 2018 and Nov 2024, across 140 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 9.3% of everything it billed.
33Billing provider infoINTEGRATED REGIONAL LABORATORIES PATHOLOGY SERVICES, LLC
ATLANTIS, FL 33462
ATLANTIS, FL 33462
33aNPI1669153011assigned 07/28/2023
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$564K
24GClaims925,917
24DCodes billed140
24AFirst – last monthDec 2018 – Nov 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Florida
Rank by total paid#27 of 207
Median peer was paid$39K
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DAVIS, MICHAEL controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 94 | $0.00 | |
| 2019 | 12,036 | $0.00 | |
| 2020 | 668 | $203.64 | |
| 2021 | 3,846 | $2K | |
| 2022 | 176,712 | $54K | |
| 2023 | 662,271 | $460K | |
| 2024incomplete | 70,290 | $48K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 9.3% | 96,763 | 56,976 | $52K |
| 85027 | 9.2% | 156,728 | 79,523 | $52K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 7.0% | 9,001 | 4,933 | $40K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 6.2% | 911 | 754 | $35K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 4.5% | 5,676 | 4,559 | $25K |
| 87400 | 4.3% | 32,081 | 14,869 | $24K | |
| 84484 | 4.2% | 31,023 | 21,179 | $23K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 4.1% | 47,576 | 24,150 | $23K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.8% | 33,098 | 23,393 | $22K |
| 83735 | 2.6% | 40,801 | 20,905 | $15K | |
| 87430 | 2.6% | 19,335 | 17,519 | $15K | |
| 87040 | 2.5% | 11,991 | 9,758 | $14K |
128 more codes
| 87070 | 2.1% | 22,651 | $12K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.9% | 12,951 | $11K |
| 84703 | 1.9% | 16,474 | $11K | |
| 81025 | 1.7% | 25,013 | $10K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1.7% | 284 | $10K |
| 83690 | 1.6% | 24,971 | $9K | |
| 82805 | 1.6% | 1,780 | $9K | |
| 83605 | 1.6% | 14,894 | $9K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.3% | 949 | $7K |
| 84702 | 1.2% | 6,205 | $7K | |
| 87276 | 1.1% | 12,937 | $6K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1.1% | 6,492 | $6K |
| 85730 | 1.1% | 17,903 | $6K | |
| 81001 | 1.0% | 33,345 | $6K | |
| 87275 | 1.0% | 9,046 | $6K | |
| 88307 | <1% | 157 | $6K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 3,340 | $5K |
| 86850 | <1% | 12,112 | $5K | |
| 80076 | <1% | 11,726 | $5K | |
| 86900 | <1% | 18,349 | $5K | |
| 81003 | <1% | 31,746 | $5K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 3,082 | $4K |
| 85610 | <1% | 22,403 | $4K | |
| 87807 | <1% | 6,065 | $4K | |
| 80320 | <1% | 1,677 | $3K | |
| 84100 | <1% | 15,507 | $3K | |
| 82803 | <1% | 1,777 | $3K | |
| 80061 | Lipid panel | <1% | 4,836 | $3K |
| 86901 | <1% | 17,901 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,738 | $3K |
| 87088 | <1% | 4,542 | $3K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 6,344 | $2K |
| 87077 | <1% | 3,370 | $2K | |
| 87420 | <1% | 3,202 | $2K | |
| 80329 | <1% | 925 | $2K | |
| 87490 | <1% | 981 | $2K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 860 | $2K |
| 82550 | <1% | 4,856 | $1K | |
| 86140 | <1% | 5,390 | $1K | |
| 86880 | <1% | 1,520 | $1K | |
| 85060 | <1% | 275 | $1K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 3,224 | $1K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,848 | $1K |
| 87186 | <1% | 2,100 | $1K | |
| 85379 | <1% | 2,341 | $881.55 | |
| 82607 | <1% | 837 | $781.64 | |
| 80202 | <1% | 664 | $762.62 | |
| 87340 | <1% | 618 | $635.84 | |
| 88304 | <1% | 53 | $633.49 | |
| 87205 | <1% | 1,874 | $593.54 | |
| 82247 | <1% | 1,428 | $587.73 | |
| 82248 | <1% | 1,136 | $567.57 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,009 | $551.46 |
| 87210 | <1% | 1,268 | $551.46 | |
| 82728 | <1% | 656 | $534.85 | |
| 82150 | <1% | 1,215 | $417.24 | |
| 85520 | <1% | 200 | $416.06 | |
| 82746 | <1% | 392 | $391.80 | |
| 80047 | <1% | 256 | $361.94 | |
| 86920 | <1% | 108 | $335.80 | |
| 84439 | <1% | 910 | $322.64 | |
| 87081 | <1% | 1,715 | $312.84 | |
| 86738 | <1% | 435 | $299.67 | |
| 86403 | <1% | 431 | $295.59 | |
| 85007 | <1% | 1,579 | $287.84 | |
| 83550 | <1% | 555 | $258.22 | |
| 88342 | <1% | 39 | $241.84 | |
| 85378 | <1% | 503 | $225.23 | |
| 86592 | <1% | 903 | $203.39 | |
| 83540 | <1% | 662 | $202.28 | |
| 84132 | <1% | 1,179 | $201.97 | |
| 83615 | <1% | 697 | $187.81 | |
| 85018 | <1% | 1,393 | $168.10 | |
| 85651 | <1% | 812 | $161.49 | |
| 85014 | <1% | 999 | $160.77 | |
| 87808 | <1% | 133 | $152.55 | |
| 83880 | <1% | 1,483 | $146.93 | |
| 84030 | <1% | 360 | $141.03 | |
| 80069 | <1% | 544 | $138.62 | |
| 81002 | <1% | 1,433 | $129.27 | |
| 82330 | <1% | 197 | $122.96 | |
| 85652 | <1% | 641 | $100.02 | |
| 87169 | <1% | 203 | $98.92 | |
| 87280 | <1% | 355 | $93.37 | |
| 82140 | <1% | 178 | $85.49 | |
| 87147 | <1% | 122 | $83.51 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 191 | $79.10 |
| 85045 | <1% | 358 | $78.07 | |
| 82570 | <1% | 530 | $77.10 | |
| 86780 | <1% | 280 | $72.78 | |
| 85384 | <1% | 217 | $63.34 | |
| 84295 | <1% | 815 | $62.82 | |
| 84156 | <1% | 677 | $62.76 | |
| 84550 | <1% | 452 | $57.06 | |
| 86701 | <1% | 252 | $47.18 | |
| 80074 | <1% | 41 | $37.27 | |
| 82947 | <1% | 112 | $35.82 | |
| 82435 | <1% | 767 | $35.81 | |
| 86706 | <1% | 50 | $34.09 | |
| 82009 | <1% | 223 | $30.63 | |
| 87045 | <1% | 13 | $27.01 | |
| 82565 | <1% | 59 | $25.50 | |
| 86703 | <1% | 26 | $23.19 | |
| 85044 | <1% | 79 | $20.15 | |
| 84165 | <1% | 178 | $16.58 | |
| 86334 | <1% | 70 | $14.05 | |
| 84450 | <1% | 16 | $10.53 | |
| 84520 | <1% | 12 | $9.99 | |
| 82540 | <1% | 107 | $8.21 | |
| 87449 | <1% | 14 | $7.36 | |
| 84134 | 0% | 57 | $0.00 | |
| 82077 | 0% | 360 | $0.00 | |
| 86870 | 0% | 12 | $0.00 | |
| 86308 | 0% | 25 | $0.00 | |
| 82270 | 0% | 13 | $0.00 | |
| 84157 | 0% | 14 | $0.00 | |
| 87487 | 0% | 13 | $0.00 | |
| 86762 | 0% | 14 | $0.00 | |
| 80306 | 0% | 420 | $0.00 | |
| 85041 | 0% | 18 | $0.00 | |
| 84145 | 0% | 35 | $0.00 | |
| 84481 | 0% | 14 | $0.00 | |
| 80164 | 0% | 54 | $0.00 | |
| 82375 | 0% | 18 | $0.00 | |
| 83020 | 0% | 14 | $0.00 | |
| 87076 | 0% | 16 | $0.00 | |
| 85049 | 0% | 17 | $0.00 | |
| 85048 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAVIS, MICHAEL (COO)
Parent organizationINTEGRATED REGIONAL LABORATORIES PATHOLOGY SERVICES, LLC
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.